Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy

Semaglutide is a long-acting glucagon-like peptide-1 receptor agonist used for management of type 2 diabetes and/or obesity. To test the hypothesis that perioperative semaglutide use is associated with delayed gastric emptying and increased residual gastric content (RGC) despite adequate preoperativ...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of clinical anesthesia Ročník 87; s. 111091
Hlavní autoři:	Silveira, Saullo Queiroz, da Silva, Leopoldo Muniz, de Campos Vieira Abib, Arthur, de Moura, Diogo Turiani Hourneaux, de Moura, Eduardo Guimarães Hourneaux, Santos, Leonardo Barbosa, Ho, Anthony M.-H., Nersessian, Rafael Souza Fava, Lima, Filipe Lugon Moulin, Silva, Marcela Viana, Mizubuti, Glenio B.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Elsevier Inc 01.08.2023 Elsevier Limited
Témata:	Analgesics Anesthesia Anesthesia, General Antidiabetics Body mass index Colonoscopy Diabetes Diabetes Mellitus, Type 2 - complications Endoscopy Endoscopy, Gastrointestinal - adverse effects Esophagogastroduodenoscopy Esophagus General anesthesia GLP-1 receptor agonists Glucagon Humans Hypoglycemic Agents - adverse effects Medical records Pain Medicine Patients Pulmonary aspiration Residual gastric content Retrospective Studies Semaglutide Upper endoscopy Weight control Upper endoscopy Esophagogastroduodenoscopy Anesthesia Semaglutide Pulmonary aspiration Residual gastric content
ISSN:	0952-8180, 1873-4529, 1873-4529
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!